Sirtex Launches Colorectal Liver Metastases Study
Posted on: Thursday, 22 May 2008, 11:53 CDT
Sirtex has launched an international clinical study evaluating the safety and efficacy of Sir-Spheres1 microspheres when administered with Folfox6 as a first line therapy in patients with non-resectable colorectal liver metastases compared to chemotherapy alone.
The Sirflox study, which will take place at 25-35 sites in Australia, the US, EU and New Zealand, is the largest of its kind. It will involve 318 patients, with progression-free survival as the primary endpoint. The trial will be conducted in the US under an FDA-approved protocol via an investigational device exemption.
Sirtex Medical's Sir-Spheres microspheres are indicated for the treatment of non-resectable metastatic colorectal cancer in combination with intra-arterial Fudr chemotherapy.
Samuel Putnam, medical director of US operations at Sirtex, said: "Our goal is that by combining SIR-Spheres microspheres with Folfox6 much earlier in the treatment process, we will document an improvement in survival time and patient quality of life."
Source: Datamonitor
Related Articles
- Sirtex Sponsors Pilot Study Evaluating SIR-Spheres(R) Microspheres for the Treatment of Unresectable Hepatocelluar Carcinoma
- Review Examines the Use of Sirtex's SIR-Spheres(R) Microspheres in Patients With Hepatic Colorectal Cancer Metastases
- Sirtex Supports the First Pilot Study Evaluating SIR-Spheres(R) Microspheres in Combination With Bevacizumab and Chemotherapy As a First Line Treatment for Metastatic Colorectal Cancer
- Repeated Treatments of SIR-Spheres(R) Microspheres Appear to Be Safe for Patients With Metastatic Liver Tumors
- Sirtex Supports Clinical Trial Evaluating SIR-Spheres(R) Microspheres for First Line Treatment of Liver Cancer
- Sirtex's SIR-Spheres(R) Microspheres to Be Featured at the Second Annual Harvard Medical School Brachytherapy Review
- Landmark Study Evaluates Sirtex SIR-Spheres(R) Microspheres in Patients With Metastatic Liver Cancer
- Sirtex Presents SIR-Spheres(R) Microspheres Data at the American Brachytherapy Society 2006 Meeting; Meeting Marks Debut of Microspheres Therapy for Liver Cancer at Annual Event
- Sirtex Announces Clinical Trial Evaluating the Use of SIR-Spheres(R) Microspheres With Xeloda(R) for Metastatic Liver Cancer; Combination Therapy Trial Signals New Trend in Microspheres Treatment
- Second Annual Symposium on Liver Directed Radiotherapy With Microspheres Showcases Latest Research on Microsphere Therapy
 |
 |
User Comments (0)
RSS Feeds